Related Experiment Video
Updated: Jun 26, 2026

An Integrated Platform for Genome-wide Mapping of Chromatin States Using High-throughput ChIP-sequencing in Tumor Tissues
Published on: April 5, 2018
Mapping the epigenome--impact for toxicology
Jennifer Marlowe1, Soon-Siong Teo, Salah-Dine Chibout
1Novartis Pharma AG, Investigative Toxicology, Preclinical Safety, Basel, Switzerland. jennifer.marlowe@novartis.com
Abstract:
Recent advances in technological approaches for mapping and characterizing the epigenome are generating a wealth of new opportunities for exploring the relationship between epigenetic modifications, human disease and the therapeutic potential of pharmaceutical drugs. While the best examples for xenobiotic-induced epigenetic perturbations come from the field of non-genotoxic carcinogenesis, there is growing evidence for the relevance of epigenetic mechanisms associated with a wide range of disease areas and drug targets. The application of epigenomic profiling technologies to drug safety sciences has great potential for providing novel insights into the molecular basis of long-lasting cellular perturbations including increased susceptibility to disease and/or toxicity, memory of prior immune stimulation and/or drug exposure, and transgenerational effects.
Insights
Technological advances in epigenome mapping offer new ways to study how epigenetic modifications link to human diseases and drug effectiveness. These epigenomic profiling tools can reveal long-lasting cellular changes relevant to drug safety and disease susceptibility.
Area of Science:
- Epigenetics and Drug Safety Science
Background:
- Recent technological advancements enable detailed epigenome mapping and characterization.
- Epigenetic modifications are increasingly linked to human diseases and drug targets.
- Xenobiotic-induced epigenetic changes are well-studied in non-genotoxic carcinogenesis.
Purpose of the Study:
- To explore the relationship between epigenetic modifications, human diseases, and pharmaceutical drug potential.
- To highlight the application of epigenomic profiling in drug safety sciences.
- To investigate the molecular basis of long-lasting cellular perturbations.
Main Methods:
- Utilizing advanced technological approaches for epigenome mapping.
- Characterizing the epigenome to understand its role in disease.
- Applying epigenomic profiling technologies to drug safety studies.
Main Results:
- New opportunities arise for studying epigenetics in relation to disease and drug therapies.
- Growing evidence supports the role of epigenetic mechanisms in various disease areas.
- Epigenomic profiling offers insights into cellular memory and transgenerational effects.
Conclusions:
- Epigenomic profiling technologies have significant potential in drug safety sciences.
- Understanding epigenetic perturbations is crucial for addressing disease susceptibility and toxicity.
- These technologies can illuminate the molecular underpinnings of long-term cellular responses to exposures.
Related Concept Videos
Epigenetic Regulation
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation
Toxic Reactions: Overview
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
Toxicokinetics: Overview
Drug Toxicity: Dose-Dependent Reactions

